Completed PHASE4 INTERVENTIONAL 2-arm NCT00830492

Clomiphene Citrate (CC)/Gonadotropin/Gonadotropin Releasing Hormone (GnRH) Antagonist Versus Gonadotropin/GnRH Agonist

Comparisin CC/Gonadotropin/GnRH Antagonist and Gonadotropin/GnRH Agonist in IVF Outcome.

Sponsor: Yazd Research & Clinical Center for Infertility

Interventions GnRH antagonist Ultrasound buserelin clomiphene citrate gonadotopin (HMG) rFSH

Updated 5 times since 2017 Last updated: Jan 27, 2009 Started: Jan 31, 2008 Primary completion: Dec 31, 2008 Completion: Dec 31, 2008

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00830492, this PHASE4 trial focuses on Ovarian Stimulation and remains completed. Sponsored by Yazd Research & Clinical Center for Infertility, it has been updated 5 times since 2008, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

5 versions recorded

Sep 2025 — Present [monthly]

Completed PHASE4
Sep 2024 — Sep 2025 [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Jan 2017 — Jan 2021 [monthly]

Completed PHASE4

First recorded

Jan 2008

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Yazd Research & Clinical Center for Infertility

Data source: Yazd Research & Clinical Center for Infertility

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Yazd, Iran